Grabowska-Andén M, Andén N E, Bárány E, Magnusson A
Acta Pharmacol Toxicol (Copenh). 1984 Mar;54(3):177-82. doi: 10.1111/j.1600-0773.1984.tb01914.x.
Conscious rats were given intracerebral injections by preplaced microsyringes. The injectates were 0.3-0.5 microliters of 125I- and 131I-o-iodohippurate. One hour after injection the isotopes present in the unopened cranial cavity were measured by gamma spectrometry. Some animals received 200 mg/kg probenecid intraperitoneally and this reduced the rate of absorption from injectates into the corpus striatum to 65.7 +/- 12.6% of control; from injectates into the cerebellum to 57.1 +/- 9.8% of control. Dye injections showed that injections into the cerebellum did not remain in the parenchyma, in contrast to injections into the corpus striatum or thalamus. Probenecid was also given as 2.9% solution, pH 7, mixed with the iodohippurate in the microsyringe. It had no effect on injections into the cerebellum, reduced the rate of absorption from the corpus striatum to 80.9 +/- 3.2% of controls and that from the thalamus to 88.3 +/- 2.2%. The results indicate parenchymal probenecid-sensitive transport of iodohippurate from the corpus striatum and thalamus but failed to settle the matter for the cerebellum.
将预放置的微量注射器用于给清醒大鼠进行脑内注射。注射物为0.3 - 0.5微升的125I - 和131I - 邻碘马尿酸盐。注射后1小时,通过γ能谱法测量未打开颅腔内的同位素。一些动物腹腔注射200mg/kg丙磺舒,这使注射物进入纹状体的吸收速率降至对照的65.7±12.6%;进入小脑的吸收速率降至对照的57.1±9.8%。染料注射显示,与注入纹状体或丘脑相比,注入小脑的染料不会留在实质内。丙磺舒也以2.9%溶液(pH 7)与微量注射器中的碘马尿酸盐混合的形式给药。它对注入小脑没有影响,使纹状体的吸收速率降至对照的80.9±3.2%,丘脑的吸收速率降至对照的88.3±2.2%。结果表明,碘马尿酸盐在纹状体和丘脑的实质内存在对丙磺舒敏感的转运,但关于小脑的情况尚无定论。